Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Bayer presents new adenosine receptor ligands and potential therapeutic applications

May 23, 2001

Antiarrhythmic agents from Aventis act on Kv1.5 channels

May 23, 2001

Small-molecule sPLA2 inhibitor appears to have beneficial effects in severe sepsis

May 23, 2001

Low-dose tolafentrine may improve efficacy of inhaled prostanoids in chronic PH therapy

May 23, 2001

Antiischemic adenosine agonists designed by Pfizer

May 22, 2001

Promising preliminary results reported for AGI-1067 in postangioplasty restenosis

May 22, 2001

Endovasc's Liprostin bypasses phase I/II and enters phase III for critical limb ischemia

May 21, 2001

Statistically significant reductions in BP reported for enalapril/nitrendipine

May 21, 2001

Selective PDE5 inhibitors reported by Icos along with potential therapeutic uses

May 18, 2001

New antiarrhythmic agents designed by Nissan to have fewer side effects

May 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...